An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

Abstract

The OST using atropine as an olfactory probe holds promise as a simple, inexpensive screen for early and preclinical AD and further work, including longitudinal studies, is needed to explore this possibility.